COMPARATIVE ACTIVATION OF AFLATOXIN B-1 BY MAMMALIAN PULMONARY TISSUES

被引:14
|
作者
BALL, RW
HUIE, JM
COULOMBE, RA
机构
[1] UTAH STATE UNIV,DEPT ANIM DAIRY & VET SCI,CTR ENVIRONM TOXICOL,TOXICOL PROGRAM,LOGAN,UT 84322
[2] UTAH STATE UNIV,DEPT ANIM DAIRY & VET SCI,CTR ENVIRONM TOXICOL,PROGRAM MOLEC BIOL,LOGAN,UT 84322
关键词
AFLATOXIN B-1; BENZO[A]PYRENE; METABOLIC ACTIVATION; LUNG TISSUE; AIRWAYS;
D O I
10.1016/0378-4274(94)03169-8
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Occupational exposures to respirable dusts contaminated with the mycotoxin aflatoxin B-1 (AFB(1)) have been associated with an increased incidence of upper airway tumors. To investigate this possible etiology we compared the abilities of tracheal and lung S9 from rabbit, hamster and rat to activate AFB(1) to mutagens in Salmonella typhimurium TA 98. The activation of AFB(1) was compared to that of benzo[a]pyrene (B[a]P), a known respiratory carcinogen. These species differ in airway morphology with respect to numbers of metabolically-active non-ciliated tracheal epithelial cells. Tracheas from hamster and rabbit and lung from rabbit were active in converting AFB(1) to bacterial mutagens. Trachea from hamster was more efficient in activating AFB(1) to mutagens than lung, while rabbit lung was over 4 times more active in converting AFB(1) to mutagens than that from trachea. In all cases, AFB(1) was more mutagenic than B[a]P. The relative capabilities of trachea to activate AFB(1) were in agreement with the ability of cultured tracheas from these species to form to AFB(1)-DNA adducts. These results demonstrate that AFB(1) is activated more efficiently than B[a]P in the lung, and that the metabolic capabilities of airway epithelium to activate AFB(1) are not predictable by airway morphology.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [1] Aflatoxin B-1 activation in human lung
    Kelly, JD
    Eaton, DL
    Guengerich, FP
    Coulombe, RA
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 144 (01) : 88 - 95
  • [2] THE EFFECT OF SCHISTOSOMIASIS ON THE ACTIVATION OF AFLATOXIN B-1
    HASLER, JA
    SIWELA, AH
    NYATHI, CB
    CHETSANGA, CJ
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1986, 51 (03): : 421 - 424
  • [3] BIOCHEMICAL AND MOLECULAR ASPECTS OF MAMMALIAN SUSCEPTIBILITY TO AFLATOXIN B-1 CARCINOGENICITY
    MASSEY, TE
    STEWART, RK
    DANIELS, JM
    LIU, L
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1995, 208 (03): : 213 - 227
  • [4] NUCLEAR ACTIVATION AND METABOLISM OF AFLATOXIN B-1 IN RAT-LIVER
    UENO, Y
    UCHIMARU, R
    YOSHIZAWA, H
    TOXICOLOGY LETTERS, 1980, : 70 - 70
  • [5] AFLATOXINS B-1,M(1) AND AFLATOXICOL IN TISSUES AND URINE OF CALVES RECEIVING AFLATOXIN
    SABINO, M
    PURCHIO, A
    MILANEZ, TV
    FOOD ADDITIVES AND CONTAMINANTS, 1995, 12 (03): : 467 - 472
  • [6] Mucosal tolerance to aflatoxin B-1
    Oliver, AR
    Silbart, LK
    Keren, DF
    Miller, B
    McDonald, RA
    ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 : 422 - 424
  • [7] Prevalence of aflatoxin and fumonisins (B-1
    Mwalwayo, Daniel S.
    Thole, Bernard
    TOXICOLOGY REPORTS, 2016, 3 : 173 - 179
  • [8] DETECTION OF AFLATOXIN B-1 BY ELISA
    BIERMANN, A
    TERPLAN, G
    ARCHIV FUR LEBENSMITTELHYGIENE, 1980, 31 (02): : 51 - 57
  • [9] Metabolic activation of aflatoxin B-1 to aflatoxin B-1-8,9-epoxide in woodchucks undergoing chronic active hepatitis
    GemechuHatewu, M
    Platt, KL
    Oesch, F
    Hacker, HJ
    Bannasch, P
    Steinberg, P
    INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (04) : 587 - 591
  • [10] ADENINE ADDUCT OF AFLATOXIN B-1 EPOXIDE
    IYER, RS
    VOEHLER, MW
    HARRIS, TM
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (20) : 8863 - 8869